Introduction
Novy and Liggins (1980) suggest that prostanoids play a physiological role in the regulation of uterine activity in a number of species. In ewes, work aimed at delineating this role has focused, almost exclusively, on alterations in prostanoid concentrations in various compartments during different phases of the reproductive cycle (Olson et al, 1986) . Scant attention has been paid to the actions of these compounds at the putative end-organ.
In humans (Senior et al, 1991 (Senior et al, , 1992 (Senior et al, , 1993 , the direct effects of prostanoids on uterine contractility are mediated through actions at seven different receptors, some of which are excit¬ atory, others inhibitory. In ewes, however, the prostanoid receptor status of the myometrium is not known.
In the present study, the prostanoid receptor status of the myometrium of nonpregnant ewes during the breeding season was determined pharmacologically by studying the effects of prostanoid receptor-selective analogues on the contractility of the myometrium in vitro.
Materials and Methods

Collection of myometrium
Reproductive tracts were obtained from two abattoirs in the vicinity of Hamilton, Ontario (43°15'N). They were collected (Cheuk el al, 1993) , since it can be used to quantify drug effects in tissues that develop significant spontaneous activity and respond to stimulation by changes in both tonic and phasic activity (Crankshaw, 1990) . Mean force was determined exactly as described by Wainman et al (1988) .
Concentration-effect curves to excitatory agonists
At the end of the equilibration period, the mean force developed during a 10 min control period was determined.
Drugs were then added to the baths, in a cumulative fashion, by increments that would produce approximately one half log unit changes in the concentration in the bath. After each addition, the mean contractile force was determined for 10 min.
The mean force recorded in 10 min immediately after agonist addition minus the mean control force was considered to be the force developed in response to that concentration of agonist. Additions were continued until further addition produced no further increase in developed force. Concentration-effect curves (response versus log molar agonist concentration) were then constructed from these data by fitting the equation
where E is the effect of the agonist, C is the molar concen¬ tration of the agonist and D is the molar concentration of the agonist that produces a half maximal response (£C50). Fig. 1 showing the concentration effect experiment. Horizontal bars indicate data collection for 10 min, the first of which is the control. Thereafter, the EP receptor agonist, GR63799x, was added cumulatively at the arrows to give concentrations in the bath ranging from 1 nmol 1~' to 1.4 µ 1~. Fig. 2 Fig. 2 and the resulting concentrationeffect curve in Fig. 3 . Table 2 shows the potencies of all the agonists tested that had excitatory effects.
There were no differences in the pD2 values obtained for 17-phenyltrinor PGE2 and GR63799x in the presence or in the absence of the EPt antagonist AH6809 (Coleman et al, 1985) The ß-adrenoceptor agonist isoprenaline and the Ca-channel antagonist D600 caused concentration-dependent inhibition of KC1-and cloprostenol-induced activity. Figure 4a shows the decline in cloprostenol-induced activity with time and Fig. 4b shows the decline in cloprostenol-induced activity in a matched strip that was treated with isoprenaline. (Giles et al, 1989) . Third, the selective DP receptor agonists, BW245c (Town et al, 1983) and ZK110841 (Thierauch et al, 1988) are ineffective. The contractile effects of PGD2 may be produced by action at EP, FP or TP receptors; however, its potency would be expected to be significantly less than those of PGE2, PGF2a or U46619, respectively ). This is Contractile activity was determined during successive 10 min collection periods, the first of which represented the control. In (b) cumulative concentrations of isoprenaline in the bath for collection 1-11 were: 0, 0.01, 0.04, 0.14, 0.44, 1.44, 4.44, 14.4, 44.4, 144.4, 444 (Ito et al, 1990 ). (Coleman et al, , 1994 .
